bromfenac ophthalmic solution

DRUG6 trials

Sponsors

Bausch & Lomb Incorporated, Ophthalmic Consultants of Boston

Conditions

CataractCataract SurgeryDiabetic Macular EdemaInflammationPain

Phase 1

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Ophthalmic Consultants of BostonDiabetic Macular Edema

Start: 2007-06-30Target: 10Updated: 2007-06-25

Phase 2

Efficacy and Safety of Bromfenac Ophthalmic Solution

CompletedNCT00585975

Bausch & Lomb IncorporatedCataract Surgery

Start: 2007-10-31Updated: 2013-02-15

Phase 3

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

CompletedNCT00333918

Bausch & Lomb IncorporatedInflammation, Pain

Start: 2006-06-30End: 2007-03-31Updated: 2013-02-15

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

CompletedNCT00703781

Bausch & Lomb IncorporatedCataract

Start: 2008-06-30Updated: 2015-03-24

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

CompletedNCT00853970

Bausch & Lomb IncorporatedInflammation, Pain

Start: 2009-02-28End: 2009-12-31Updated: 2013-01-25

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

CompletedNCT01367249

Bausch & Lomb IncorporatedCataract, Inflammation, Pain

Start: 2011-05-31End: 2011-12-31Updated: 2014-05-06